Ticker
CLDXCompany Name
CELLDEX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 692.41M | $ 23.04M | 3.33% |
3/31/2025 | $ 739.47M | $ 17.14M | 2.32% |
12/31/2024 | $ 792.34M | $ 28.36M | 3.58% |
9/30/2024 | $ 823.18M | $ 36.4M | 4.42% |
6/30/2024 | $ 845.59M | $ 42.74M | 5.05% |
3/31/2024 | $ 868.85M | $ 115.08M | 13.24% |
12/31/2023 | $ 465.63M | $ 34.81M | 7.48% |
9/30/2023 | $ 280.26M | $ 21.13M | 7.54% |
6/30/2023 | $ 299.31M | $ 28.22M | 9.43% |
3/31/2023 | $ 324.52M | $ 54.12M | 16.68% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CELLDEX THERAPEUTICS INC is calculated as follows: CashnEq [ $ 18.15M ] / Assets [ $ 255.77M ]
(=) Cash to Assets [ 7.1% ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |